Przejdź do zawartości
· Skin boostery
SKU 11122

Aquashine HA

Dostępny
Objętość
1 x 2 mL
Laboratorium
Caregen Co., Ltd.
Pochodzenie
Korea Południowa
Wskazanie
Skin hydration, revitalization and age-related correction
Obszary zabiegowe
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Najważniejsze zalety: Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Najważniejsze informacje
Marka AQUASHINE
Producent Caregen Co., Ltd.
Kraj pochodzenia South Korea
Certyfikacja CE marked (per MDD 93/42/EEC)
Skład Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
Objętość / Rozmiar 2 ml
Opakowanie 1 x 2 mL
Rozmiar igły 30G (0.30 x 13 mm)
Rodzaj zastosowania For professional use - intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
Głębokość iniekcji Middle and superficial dermis
Protokół / Czas trwania Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

Zastosowanie profesjonalne

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

Obszary zabiegowe

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

Profil pacjenta

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

Jak działa Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty AQUASHINE od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z certyfikatem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z dedykowanym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

Więcej od Caregen

Zobacz laboratorium

Alternatywy dla kliniki

Wszystkie produkty

Aquashine HA

Dostępny
Oznaczenie CE Oznaczenie CE Aquashine HA
Ceny tylko dla zweryfikowanych
Zaloguj się lub załóż konto B2B, aby zobaczyć swoją cenę.
Konto B2B

Aquashine HA is a sterile injectable intradermal implant manufactured by Caregen Co., Ltd. in South Korea, based on cross-linked hyaluronic acid and designed to smooth wrinkles and folds. Placed in the middle and superficial dermis, the gel binds water in the tissue to restore dermal density and the facial oval and to provide deep hydration. Its sodium hyaluronate is of non-animal, biosynthetic origin and is cross-linked with BDDE, with residual BDDE below 1 ppm. The implant is CE-marked and supplied for professional use by appropriately trained practitioners only.

*Note: The manufacturer does not currently list this reference on their website. Please confirm current availability with ALLPARA before purchasing.

Najważniejsze zalety: Aquashine HA

  • Cross-linked hyaluronic acid at 15 mg/ml (sodium hyaluronate), of non-animal biosynthetic origin
  • Placed in the middle and superficial dermis to restore dermal density and smooth wrinkles and folds
  • Restores the skin's hydrobalance and supports lifting and restoration of the facial oval
  • Suited to the nasolabial and oral-chin folds, chin and cheekbones
  • Supplied as a 3 ml syringe filled with 2 ml of gel, with two sterile 30G 13 mm needles
  • Manufactured by Caregen Co., Ltd. (South Korea); CE-marked, single use only
Najważniejsze informacje
Marka AQUASHINE
Producent Caregen Co., Ltd.
Kraj pochodzenia South Korea
Certyfikacja CE marked (per MDD 93/42/EEC)
Skład Cross-linked sodium hyaluronate 15 mg/ml (1.5%); sodium chloride 6.1 mg/ml; sodium hydroxide 2.7 mg/ml; monosodium phosphate 0.8 mg/ml; disodium phosphate 1.4 mg/ml; sodium bisulfate monohydrate 1.9 mg/ml; 1,4-butanediol diglycidyl ether (BDDE) 0.000021 mg/ml (residual below 1 ppm); protein 0.00046 mg/ml; water for injection to 1.0 ml
Objętość / Rozmiar 2 ml
Opakowanie 1 x 2 mL
Rozmiar igły 30G (0.30 x 13 mm)
Rodzaj zastosowania For professional use - intradermal hyaluronic acid implant, administered only by qualified practitioners trained in injection technique
Głębokość iniekcji Middle and superficial dermis
Protokół / Czas trwania Usually one treatment course, occasionally two; aesthetic effect retained 1 to 6 months

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Correction of wrinkles and folds of the facial tissues
  • Restoration and modelling of volume, and replenishment of missing tissue volume
  • Restoration of the skin's hydrobalance and tissue structure
  • Correction of the shape and volume of the lips, cheekbones and facial oval
  • Rejuvenation of the hands
  • Hydration and rejuvenation of the skin

Zastosowanie profesjonalne

Aquashine HA is intended for administration only by qualified medical personnel trained in intradermal injection technique, using aseptic technique. It is placed in the middle and superficial dermis using the supplied 30G (0.30 x 13 mm) needle, by linear (threading), linear-point, point or grid technique. It must not be combined with implants or gels from other manufacturers in a single procedure; injection into the eyelids and intravascular injection are strictly prohibited. Single use, one patient only; do not re-sterilise. Patient selection, injection technique and aftercare remain the responsibility of the treating practitioner.

Obszary zabiegowe

  • Nasolabial folds
  • Oral-chin (labiomental) folds
  • Chin
  • Cheekbones

Profil pacjenta

Suitable for adult patients seeking correction of wrinkles and folds, restoration of hydrobalance and dermal structure, and rejuvenation of the skin, as assessed by a qualified practitioner. Contraindicated in pregnancy and lactation, allergy to any component, systemic retinoid, anticoagulant/antithrombotic or immunosuppressive therapy, inflammatory infiltrates, progressive chronic dermatoses, herpetic infection, paraneoplastic processes at the injection site, and decompensated severe somatic disease. In patients under 18, only with the consent of a legal representative.

Jak działa Aquashine HA ​

Aquashine HA is a cross-linked hyaluronic acid gel at 15 mg/ml of sodium hyaluronate in a phosphate buffer. Placed in the middle and superficial dermis, the cross-linked hyaluronic acid binds water in the tissue, so the effect is restored moisture, improved dermal density and smoothing of wrinkles and folds rather than deep volumising. Full resorption occurs at approximately one month, with the aesthetic effect retained from one to six months depending on the skin, the wrinkle and the technique used.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty AQUASHINE z pełną identyfikowalnością partii, produktami z certyfikatem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.

Najczęściej zadawane pytania

What is in Aquashine HA?

Cross-linked sodium hyaluronate at 15 mg/ml in a phosphate buffer, of non-animal biosynthetic origin, cross-linked with BDDE (residual BDDE below 1 ppm).

Where is Aquashine HA injected?

Into the middle and superficial dermis, using the supplied 30G 13 mm needle. It is directed at the nasolabial and oral-chin folds, the chin and the cheekbones.

How does Aquashine HA differ from Aquashine HA BR?

Aquashine HA is the 15 mg/ml, medium-viscosity variant (25.0 Pa·s), directed at the nasolabial and oral-chin folds, the chin and the cheekbones. Aquashine HA BR is the 13 mg/ml, lower-viscosity variant (18.0 Pa·s), directed at the periorbital zone, neck, lips and forehead.

Więcej od Caregen

Zobacz laboratorium →
* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).